Breaking News Instant updates and real-time market news.

HP

Helmerich & Payne

$40.51 /

-0.57 (-1.39%)

09:15
09/30/19
09/30
09:15
09/30/19
09:15

Helmerich & Payne downgraded to Neutral from Buy at Citi

Citi analyst Scott Gruber downgraded Helmerich & Payne to Neutral from Buy and lowered his price target for the shares to $43 from $50. The analyst recently cut his 2020 U.S. rig count forecast, which now calls for a 5% year-over-year decline next year. Falling utilization across both super spec and standard rig classes likely weigh on pricing, Gruber tells investors in a research note. The analyst adds that despite the recent pullback in shares of land drillers, his estimates are now ~30% below consensus for 2020.

HP Helmerich & Payne
$40.51 /

-0.57 (-1.39%)

09/30/19 Citi
Helmerich & Payne downgraded to Neutral from Buy at Citi
09/26/19 Barclays
Nabors Industries initiated with an Overweight at Barclays
09/26/19 Barclays
Helmerich & Payne initiated with an Overweight at Barclays
09/12/19 Wells Fargo
Wells Fargo downgrades Land Drillers sector to Underweight, cuts three stocks

TODAY'S FREE FLY STORIES

Recommendations
RingCentral price target raised to $330 from $300 at Oppenheimer » 07:45
08/04/20
08/04
07:45
08/04/20
07:45
RNG

RingCentral

$305.78 /

+15.88 (+5.48%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNG RingCentral
$305.78 /

+15.88 (+5.48%)

RNG RingCentral
$305.78 /

+15.88 (+5.48%)

07:23 Today KeyBanc
RingCentral price target raised to $350 from $315 at KeyBanc
05:10 Today Jefferies
RingCentral price target raised to $370 from $300 at Jefferies
07/28/20 Deutsche Bank
RingCentral price target raised to $310 from $275 at Deutsche Bank
07/27/20 Rosenblatt
Vonage initiated with a Neutral at Rosenblatt
RNG RingCentral
$305.78 /

+15.88 (+5.48%)

  • 13
    Nov
RNG RingCentral
$305.78 /

+15.88 (+5.48%)

RNG RingCentral
$305.78 /

+15.88 (+5.48%)

RNG RingCentral
$305.78 /

+15.88 (+5.48%)

Recommendations
Trex Company price target raised to $140 from $126 at Truist » 07:45
08/04/20
08/04
07:45
08/04/20
07:45
TREX

Trex Company

$144.39 /

+5.12 (+3.68%)

Truist analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TREX Trex Company
$144.39 /

+5.12 (+3.68%)

TREX Trex Company
$144.39 /

+5.12 (+3.68%)

07/21/20 Benchmark
Trex Company downgraded to Hold on high expectations at Benchmark
07/21/20 Benchmark
Trex Company downgraded to Hold from Buy at Benchmark
07/14/20 DA Davidson
Trex Company price target raised to $110 from $85 at DA Davidson
07/08/20 SunTrust
Trex Company price target raised to $126 from $99 at SunTrust
TREX Trex Company
$144.39 /

+5.12 (+3.68%)

TREX Trex Company
$144.39 /

+5.12 (+3.68%)

Earnings
Allegheny Technologies reports Q2 adj. EPS (2c), consensus (12c) » 07:44
08/04/20
08/04
07:44
08/04/20
07:44
ATI

Allegheny Technologies

$8.88 /

+0.18 (+2.07%)

Reports Q2 revenue $770M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATI Allegheny Technologies
$8.88 /

+0.18 (+2.07%)

ATI Allegheny Technologies
$8.88 /

+0.18 (+2.07%)

06/08/20
Fly Intel: Top five analyst downgrades
06/08/20 BofA
Allegheny Technologies downgraded to Underperform on aerospace exposure at BofA
06/08/20 BofA
Allegheny Technologies downgraded to Underperform from Buy at BofA
03/20/20 Barclays
Allegheny Technologies downgraded to Underweight from Equal Weight at Barclays
ATI Allegheny Technologies
$8.88 /

+0.18 (+2.07%)

ATI Allegheny Technologies
$8.88 /

+0.18 (+2.07%)

Hot Stocks
Zai Lab announcesChina NMPA priority review for ripretinib NDA » 07:44
08/04/20
08/04
07:44
08/04/20
07:44
ZLAB

Zai Lab

$79.71 /

+3.53 (+4.63%)

Zai Lab announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZLAB Zai Lab
$79.71 /

+3.53 (+4.63%)

ZLAB Zai Lab
$79.71 /

+3.53 (+4.63%)

07/09/20 Roth Capital
Turning Point agreement with Zai Lab favorable, says Roth Capital
07/08/20 Guggenheim
Zai Lab price target raised to $105 from $75 at Guggenheim
07/07/20 SVB Leerink
Zai Lab price target raised to $93 from $79 at SVB Leerink
07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
ZLAB Zai Lab
$79.71 /

+3.53 (+4.63%)

  • 23
    Jan
Recommendations
Mimecast price target raised to $53 from $48 at Oppenheimer » 07:43
08/04/20
08/04
07:43
08/04/20
07:43
MIME

Mimecast

$46.76 /

-0.17 (-0.36%)

Oppenheimer analyst Shaul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIME Mimecast
$46.76 /

-0.17 (-0.36%)

MIME Mimecast
$46.76 /

-0.17 (-0.36%)

06:56 Today Barclays
Mimecast price target raised to $61 from $48 at Barclays
05:43 Today JPMorgan
Mimecast downgraded to Underweight from Neutral at JPMorgan
05:01 Today Jefferies
Mimecast price target raised to $55 from $50 at Jefferies
07/28/20 Jefferies
Mimecast price target raised to $50 from $45 at Jefferies
MIME Mimecast
$46.76 /

-0.17 (-0.36%)

MIME Mimecast
$46.76 /

-0.17 (-0.36%)

Downgrade
Boise Cascade cut to Neutral at DA Davidson after 'monster run' in price » 07:43
08/04/20
08/04
07:43
08/04/20
07:43
BCC

Boise Cascade

$47.29 /

+0.69 (+1.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCC Boise Cascade
$47.29 /

+0.69 (+1.48%)

BCC Boise Cascade
$47.29 /

+0.69 (+1.48%)

06:43 Today DA Davidson
Boise Cascade downgraded to Neutral from Buy at DA Davidson
05/26/20 BofA
Boise Cascade upgraded to Buy from Neutral at BofA
05/26/20 BofA
Boise Cascade upgraded to Buy from Neutral at BofA
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
BCC Boise Cascade
$47.29 /

+0.69 (+1.48%)

BCC Boise Cascade
$47.29 /

+0.69 (+1.48%)

Hot Stocks
Canacol Energy closes new credit agreements » 07:43
08/04/20
08/04
07:43
08/04/20
07:43
CNNEF

Canacol Energy

$0.00 /

+ (+0.00%)

Canacol Energy is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNNEF Canacol Energy
$0.00 /

+ (+0.00%)

CNNEF Canacol Energy
$0.00 /

+ (+0.00%)

05/15/20 Scotiabank
Canacol Energy price target lowered to C$6 from C$6.50 at Scotiabank
05/14/20 BMO Capital
Canacol Energy price target lowered to C$5 from C$5.50 at BMO Capital
03/02/20 BMO Capital
Canacol Energy initiated with an Outperform at BMO Capital
Earnings
Ares Capital reports Q2 Core EPS 39c, consensus 38c » 07:42
08/04/20
08/04
07:42
08/04/20
07:42
ARCC

Ares Capital

$14.44 /

+0.34 (+2.41%)

Reports Q2 NII per share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

Hot Stocks
Eloxx Pharmaceuticals receives Orphan Drug designation for ELX-02 » 07:41
08/04/20
08/04
07:41
08/04/20
07:41
ELOX

Eloxx Pharmaceuticals

$3.00 /

+0.22 (+7.91%)

Eloxx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELOX Eloxx Pharmaceuticals
$3.00 /

+0.22 (+7.91%)

ELOX Eloxx Pharmaceuticals
$3.00 /

+0.22 (+7.91%)

06/17/20 Piper Sandler
Piper Sandler backs Overweight on Eloxx as cystic fibrosis trials resume
06/11/20
Fly Intel: Top five analyst downgrades
06/11/20 Citi
Citi downgrades Eloxx Pharmaceuticals on cystic fibrosis trial pause
06/10/20 Citi
Eloxx Pharmaceuticals downgraded to Neutral from Buy at Citi
ELOX Eloxx Pharmaceuticals
$3.00 /

+0.22 (+7.91%)

ELOX Eloxx Pharmaceuticals
$3.00 /

+0.22 (+7.91%)

Hot Stocks
Pacira announces FDA acceptance of sNDA for EXPAREL use » 07:40
08/04/20
08/04
07:40
08/04/20
07:40
PCRX

Pacira

$54.88 /

+2.26 (+4.29%)

Pacira BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
$54.88 /

+2.26 (+4.29%)

PCRX Pacira
$54.88 /

+2.26 (+4.29%)

07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
PCRX Pacira
$54.88 /

+2.26 (+4.29%)

PCRX Pacira
$54.88 /

+2.26 (+4.29%)

General news
Treasury Market Outlook: bonds have richened as stock gains are unwound » 07:40
08/04/20
08/04
07:40
08/04/20
07:40

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Varonis price target raised to $125 from $95 at Oppenheimer » 07:39
08/04/20
08/04
07:39
08/04/20
07:39
VRNS

Varonis

$105.97 /

-1.85 (-1.72%)

Oppenheimer analyst Shaul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$105.97 /

-1.85 (-1.72%)

VRNS Varonis
$105.97 /

-1.85 (-1.72%)

06:58 Today Benchmark
Varonis price target raised to $130 from $112 at Benchmark
06:43 Today RBC Capital
Varonis price target raised to $121 from $115 at RBC Capital
06:29 Today Piper Sandler
Varonis price target raised to $130 from $110 at Piper Sandler
05:04 Today Jefferies
Varonis price target raised to $135 from $130 at Jefferies
VRNS Varonis
$105.97 /

-1.85 (-1.72%)

VRNS Varonis
$105.97 /

-1.85 (-1.72%)

Recommendations
PayPal price target raised to $228 from $194 at Stephens » 07:39
08/04/20
08/04
07:39
08/04/20
07:39
PYPL

PayPal

$197.09 /

+0.87 (+0.44%)

Stephens analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$197.09 /

+0.87 (+0.44%)

PYPL PayPal
$197.09 /

+0.87 (+0.44%)

08/03/20 Barclays
PayPal price target raised to $228 from $210 at Barclays
07/31/20 Keefe Bruyette
PayPal price target raised to $220 from $205 at Keefe Bruyette
07/30/20 Wedbush
PayPal price target raised to $220 from $200 at Wedbush
07/30/20 Wells Fargo
PayPal price target raised to $215 from $200 at Wells Fargo
PYPL PayPal
$197.09 /

+0.87 (+0.44%)

PYPL PayPal
$197.09 /

+0.87 (+0.44%)

PYPL PayPal
$197.09 /

+0.87 (+0.44%)

PYPL PayPal
$197.09 /

+0.87 (+0.44%)

Hot Stocks
NexPoint Residential continues to withhold its FY20 guidance » 07:38
08/04/20
08/04
07:38
08/04/20
07:38
NXRT

NexPoint Residential

$38.00 /

+0.17 (+0.45%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
11/22/19 National Securities
NexPoint Residential initiated with a Buy at National Securities
10/31/19 Raymond James
NexPoint Residential downgraded to Outperform on valuation at Raymond James
NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

Earnings
NexPoint Residential reports Q2 AFFO 66c, consensus 61c » 07:38
08/04/20
08/04
07:38
08/04/20
07:38
NXRT

NexPoint Residential

$38.00 /

+0.17 (+0.45%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
11/22/19 National Securities
NexPoint Residential initiated with a Buy at National Securities
10/31/19 Raymond James
NexPoint Residential downgraded to Outperform on valuation at Raymond James
NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

NXRT NexPoint Residential
$38.00 /

+0.17 (+0.45%)

Hot Stocks
Strongbridge Biopharma expects cash to fund operations through 1Q22  07:37
08/04/20
08/04
07:37
08/04/20
07:37
SBBP

Strongbridge Biopharma

$3.57 /

+0.21 (+6.25%)

 
ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
09/24/19 Evercore ISI
Strongbridge Biopharma initiated with an Outperform at Evercore ISI
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

Hot Stocks
Strongbridge Biopharma expects results from LOGICS study in September » 07:37
08/04/20
08/04
07:37
08/04/20
07:37
SBBP

Strongbridge Biopharma

$3.57 /

+0.21 (+6.25%)

The Company anticipates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
09/24/19 Evercore ISI
Strongbridge Biopharma initiated with an Outperform at Evercore ISI
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

Recommendations
GW Pharmaceuticals price target raised to $183 from $166 at Oppenheimer » 07:37
08/04/20
08/04
07:37
08/04/20
07:37
GWPH

GW Pharmaceuticals

$132.96 /

+5.095 (+3.98%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GWPH GW Pharmaceuticals
$132.96 /

+5.095 (+3.98%)

GWPH GW Pharmaceuticals
$132.96 /

+5.095 (+3.98%)

08/03/20 Cantor Fitzgerald
GW Pharmaceuticals price target raised to $165 from $160 at Cantor Fitzgerald
07/15/20
Fly Intel: Top five analyst downgrades
07/14/20 Stifel
GW Pharmaceuticals downgraded to Hold from Buy at Stifel
06/30/20 Evercore ISI
GW Pharmaceuticals price target raised to $275 from $250 at Evercore ISI
GWPH GW Pharmaceuticals
$132.96 /

+5.095 (+3.98%)

GWPH GW Pharmaceuticals
$132.96 /

+5.095 (+3.98%)

Earnings
Strongbridge Biopharma sees FY20 KEVEYIS revenue $22M-$26M » 07:36
08/04/20
08/04
07:36
08/04/20
07:36
SBBP

Strongbridge Biopharma

$3.57 /

+0.21 (+6.25%)

Revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
09/24/19 Evercore ISI
Strongbridge Biopharma initiated with an Outperform at Evercore ISI
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

Earnings
Strongbridge Biopharma reports Q2 adj. EPS (12c), consensus (21c) » 07:36
08/04/20
08/04
07:36
08/04/20
07:36
SBBP

Strongbridge Biopharma

$3.57 /

+0.21 (+6.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
09/24/19 Evercore ISI
Strongbridge Biopharma initiated with an Outperform at Evercore ISI
SBBP Strongbridge Biopharma
$3.57 /

+0.21 (+6.25%)

Hot Stocks
CME Group reports July average daily volume of 13.6M contracts » 07:35
08/04/20
08/04
07:35
08/04/20
07:35
CME

CME Group

$163.00 /

-3.18 (-1.91%)

Open interest at the end…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CME CME Group
$163.00 /

-3.18 (-1.91%)

CME CME Group
$163.00 /

-3.18 (-1.91%)

07/30/20 Deutsche Bank
CME Group price target lowered to $178 from $196 at Deutsche Bank
07/06/20 Wells Fargo
CME Group price target lowered to $176 from $186 at Wells Fargo
06/24/20 JPMorgan
CME Group shares could continue to underperform, says JPMorgan
06/23/20 Credit Suisse
CME Group price target lowered to $183 from $190 at Credit Suisse
CME CME Group
$163.00 /

-3.18 (-1.91%)

CME CME Group
$163.00 /

-3.18 (-1.91%)

CME CME Group
$163.00 /

-3.18 (-1.91%)

Hot Stocks
Sonnet BioTherapeutics enters LOI for SON-081, SON-080 license agreements » 07:35
08/04/20
08/04
07:35
08/04/20
07:35
SONN

Sonnet BioTherapeutics

$3.50 /

-0.65 (-15.66%)

Sonnet BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SONN Sonnet BioTherapeutics
$3.50 /

-0.65 (-15.66%)

SONN Sonnet BioTherapeutics
$3.50 /

-0.65 (-15.66%)

06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
SONN Sonnet BioTherapeutics
$3.50 /

-0.65 (-15.66%)

Options
Unusual call flow in option market yesterday » 07:35
08/04/20
08/04
07:35
08/04/20
07:35
PINS

Pinterest

$36.07 /

+1.775 (+5.18%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$36.07 /

+1.775 (+5.18%)

PINS Pinterest
$36.07 /

+1.775 (+5.18%)

08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Wedbush
Pinterest price target raised to $39 from $31 at Wedbush
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
08/03/20 JPMorgan
Pinterest price target raised to $37 from $26 at JPMorgan
PINS Pinterest
$36.07 /

+1.775 (+5.18%)

  • 16
    Oct
PINS Pinterest
$36.07 /

+1.775 (+5.18%)

PINS Pinterest
$36.07 /

+1.775 (+5.18%)

PINS Pinterest
$36.07 /

+1.775 (+5.18%)

Hot Stocks
Resideo sees net benefits of $30M-$40M in 2020 from F&O review » 07:34
08/04/20
08/04
07:34
08/04/20
07:34
REZI

Resideo

$11.15 /

-2.135 (-16.08%)

During the second…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$11.15 /

-2.135 (-16.08%)

REZI Resideo
$11.15 /

-2.135 (-16.08%)

06/08/20 Imperial Capital
Resideo price target raised to $10 from $6 at Imperial Capital
04/28/20 Imperial Capital
Resideo downgraded to In-Line from Outperform at Imperial Capital
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Resideo initiated with a Neutral at Roth Capital
REZI Resideo
$11.15 /

-2.135 (-16.08%)

Upgrade
Altice USA upgraded to Buy from Hold at TD Securities » 07:34
08/04/20
08/04
07:34
08/04/20
07:34
ATUS

Altice USA

$27.26 /

+0.27 (+1.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

08/03/20 Deutsche Bank
Altice USA price target raised to $40 from $34 at Deutsche Bank
08/03/20 UBS
Charter price target raised to $650 from $575 at UBS
07/15/20 HSBC
Altice USA upgraded to Buy from Hold at HSBC
06/26/20 Nomura Instinet
Comcast 'green shoots' are emerging, says Nomura Instinet
ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

  • 23
    Jun
  • 06
    May
  • 11
    Sep
  • 16
    Aug
ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.